Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TURPIE, Alexander G. G")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 119

  • Page / 5
Export

Selection :

  • and

Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseasesTURPIE, Alexander G. G.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 6, pp 1238-1247, issn 1079-5642, 10 p.Article

Rivaroxaban for the prevention and treatment of venous thromboembolismTURPIE, Alexander G. G.Fundamental & clinical pharmacology. 2012, Vol 26, Num 1, pp 33-38, issn 0767-3981, 6 p.Conference Paper

New oral anticoagulants in atrial fibrillationTURPIE, Alexander G. G.European heart journal. 2008, Vol 29, Num 2, issn 0195-668X, 141-143, 155-165 [14 p.]Article

Overview of the clinical results of pentasaccharide in major orthopedic surgeryTURPIE, Alexander G. G.Haematologica (Roma). 2001, Vol 86, Num 11, pp 59-62, issn 0390-6078, SUP2Article

New approaches to anticoagulation: Oral factor Xa inhibitorsTURPIE, Alexander G. G.Thrombosis and haemostasis. 2009, Vol JUN, pp 16-20, issn 0340-6245, 5 p., HSConference Paper

Optimizing prophylaxis of venous thromboembolismTURPIE, Alexander G. G.Seminars in thrombosis and hemostasis. 2002, Vol 28, pp 25-32, issn 0094-6176, SUP2Conference Paper

Thromboprophylaxis in medical patients: the role of low-molecular-weight heparinTURPIE, Alexander G. G; NORRIS, Timothy M.Thrombosis and haemostasis. 2004, Vol 92, Num 1, pp 3-12, issn 0340-6245, 10 p.Article

Fondaparinux sodiumTURPIE, Alexander G. G; GALLUS, Alexander S.Drugs (Basel). 2002, Vol 62, Num 11, pp 1686-1687, issn 0012-6667Article

Venous and arterial thrombosis ― pathogenesis and the rationale for anticoagulationTURPIE, Alexander G. G; ESMON, Charles.Thrombosis and haemostasis. 2011, Vol 105, Num 4, pp 586-596, issn 0340-6245, 11 p.Article

Applying risk assessment models in general surgery : overview of our clinical experienceAGENO, W.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S71-S78, issn 0957-5235, SUP2Conference Paper

Limitations of established antithrombotic strategiesHAAS, S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S11-S18, issn 0957-5235, SUP2Conference Paper

Perioperative management of patients receiving oral anticoagulants: A systematic reviewDUNN, Andrew S; TURPIE, Alexander G. G.Archives of internal medicine (1960). 2003, Vol 163, Num 8, pp 901-908, issn 0003-9926, 8 p.Article

Unstable angina and non-ST-elevation myocardial infarction: Initial antithrombotic therapy and early invasive strategyCANNON, Christopher P; TURPIE, Alexander G. G.Circulation (New York, N.Y.). 2003, Vol 107, Num 21, pp 2640-2645, issn 0009-7322, 6 p.Article

Selective factor Xa inhibition with fondaparinux : from concept to clinical benefitTURPIE, Alexander G. G.European heart journal supplements. 2008, Vol 10, Num C, issn 1520-765X, C1-C7Article

Low-molecular-weight heparins in the treatment of acute coronary syndromesTURPIE, Alexander G. G; ANTMAN, Elliott M.Archives of internal medicine (1960). 2001, Vol 161, Num 12, pp 1484-1489, issn 0003-9926Article

Low-molecular-weight heparins in arterial thrombosis: managing cardiovascular disordersFAREED, Jawed; TURPIE, Alexander G. G.The American journal of cardiology. 1998, Vol 82, Num 5B, issn 0002-9149, 39 p.Serial Issue

Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disordersTURPIE, Alexander G. G.American journal of health-system pharmacy. 2003, Vol 60, pp 20-24, issn 1079-2082, 5 p., SUP7Conference Paper

New standards in antithrombotic therapy: concepts, clinical evidence, and applicationsBüLLER, Harry R; TURPIE, Alexander G. G.Seminars in thrombosis and hemostasis. 2002, Vol 28, issn 0094-6176, 51 p., SUP2Conference Proceedings

PentasaccharidesTURPIE, Alexander G. G.Seminars in hematology. 2002, Vol 39, Num 3, pp 158-171, issn 0037-1963Article

Setting a standard for venous thromboembolism prophylaxisTURPIE, Alexander G. G.American journal of health-system pharmacy. 2001, Vol 58, Num 21, pp S18-S23, issn 1079-2082, SUP2Article

Pentasaccharide Org31540/SR90107A clinical trials update : Lessons for practiceTURPIE, Alexander G. G.The American heart journal. 2001, Vol 142, Num 2, pp S9-S15, issn 0002-8703, SUPConference Paper

Applying risk assessment models in non-surgical patients : effective risk stratificationELDOR, A.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S91-S97, issn 0957-5235, SUP2Conference Paper

A Symposium: New Frontiers in the Management of Unstable Coronary Artery DiseaseTURPIE, Alexander G. G; WALLENTIN, Lars.The American journal of cardiology. 1997, Vol 80, Num 5A, issn 0002-9149, 70 p.Conference Proceedings

Reactivation of the coagulation system : Rationale for long-term antithrombotic treatmentKONTNY, F.The American journal of cardiology. 1997, Vol 80, Num 5A, pp 55E-60E, issn 0002-9149Conference Paper

Venous thromboembolism management: where do novel anticoagulants fit?SPYROPOULOS, Alex C; TURPIE, Alexander G. G.Current medical research and opinion. 2013, Vol 29, Num 7, pp 783-790, issn 0300-7995, 8 p.Article

  • Page / 5